Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Inovio Pharmaceuticals - 27 Year Stock Price History | INO

Historical daily share price chart and data for Inovio Pharmaceuticals since 1998 adjusted for splits and dividends. The latest closing stock price for Inovio Pharmaceuticals as of January 03, 2025 is 1.96.
  • The all-time high Inovio Pharmaceuticals stock closing price was 2292.48 on March 03, 2000.
  • The Inovio Pharmaceuticals 52-week high stock price is 14.75, which is 652.6% above the current share price.
  • The Inovio Pharmaceuticals 52-week low stock price is 1.74, which is 11.2% below the current share price.
  • The average Inovio Pharmaceuticals stock price for the last 52 weeks is 7.90.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Inovio Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 1.8900 1.8200 1.9600 1.8200 1.9600 7.10%
2024 7.9387 6.7680 13.8800 1.7800 1.8300 -70.10%
2023 8.8625 18.2400 22.9200 4.1856 6.1200 -67.31%
2022 30.3041 62.4000 62.4000 16.9200 18.7200 -68.74%
2021 101.6771 116.7600 203.5200 59.8800 59.8800 -43.62%
2020 141.5177 38.5200 380.2800 35.7600 106.2000 168.18%
2019 37.4964 50.6400 61.2000 23.6400 39.6000 -17.50%
2018 56.4404 56.1600 73.3200 46.5600 48.0000 -3.15%
2017 75.3810 84.8400 104.1600 49.5600 49.5600 -40.49%
2016 100.2062 76.8000 136.6800 59.0400 83.2800 3.27%
2015 92.5067 111.8400 127.2000 67.8000 80.6400 -26.80%
2014 126.9279 137.7600 183.3600 96.0000 110.1600 -20.86%
2013 61.7668 24.1536 144.0000 24.1536 139.2000 480.58%
2012 26.4110 20.8800 35.5200 19.2000 23.9760 16.71%
2011 39.4152 56.6400 72.9600 17.7600 20.5440 -62.78%
2010 56.2837 52.8000 71.5200 37.3632 55.2000 0.88%
2009 47.5165 24.9600 152.6400 13.4400 54.7200 119.23%
2008 38.8595 45.1200 69.6000 7.6800 24.9600 -43.48%
2007 117.5131 157.9200 200.1600 40.8000 44.1600 -72.04%
2006 124.5071 117.6000 172.3200 96.0000 157.9200 44.93%
2005 150.3252 187.2000 240.4800 95.5200 108.9600 -42.39%
2004 231.4705 266.8800 364.8000 120.0000 189.1200 -21.20%
2003 130.2400 53.7600 264.9600 46.0800 240.0000 362.96%
2002 79.5962 124.8000 163.2000 26.8800 51.8400 -57.81%
2001 177.4262 180.0000 326.4000 72.9600 122.8800 -31.73%
2000 641.8240 648.0000 2292.4799 144.0000 180.0000 -71.15%
1999 614.5036 660.0960 780.0960 444.0960 624.0000 -1.90%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.048B $0.001B
Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. Inovio's clinical programs include human papillomavirus (HPV)/cervical cancer (therapeutic), avian influenza (preventative), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) vaccines. It is advancing preclinical research for a universal seasonal/pandemic influenza vaccine. The Company's partners and collaborators include University of Pennsylvania, National Microbiology Laboratory of the Public Health Agency of Canada, NIAID, Merck, ChronTech, University of Southampton, and HIV Vaccines Trial Network. Inovio Pharmaceuticals, Inc. is headquartered in Blue Bell, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $139.371B 13.49
Bristol Myers Squibb (BMY) United States $115.180B 48.54
Gilead Sciences (GILD) United States $114.507B 20.74
Vertex Pharmaceuticals (VRTX) United States $104.495B 0.00
CSL (CSLLY) Australia $84.407B 0.00
Regeneron Pharmaceuticals (REGN) United States $78.592B 17.89
GSK (GSK) United Kingdom $70.363B 8.14
Argenex SE (ARGX) Netherlands $37.438B 0.00
Alnylam Pharmaceuticals (ALNY) United States $30.133B 0.00
BioNTech SE (BNTX) Germany $27.642B 0.00
Biogen (BIIB) United States $21.858B 9.39
Illumina (ILMN) United States $20.766B 75.68
BeiGene (ONC) Cayman Islands $17.962B 0.00
Moderna (MRNA) United States $16.162B 0.00
Genmab (GMAB) Denmark $13.897B 20.39
Incyte (INCY) United States $13.395B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.672B 29.42
Insmed (INSM) United States $12.514B 0.00
Sarepta Therapeutics (SRPT) United States $11.853B 106.97
Bio-Techne Corp (TECH) United States $11.358B 43.85
Exact Sciences (EXAS) United States $10.535B 0.00
Vaxcyte (PCVX) United States $10.382B 0.00
QIAGEN (QGEN) Netherlands $10.160B 20.90
Swedish Orphan Biovitrum (BIOVF) Sweden $10.075B 41.62
Exelixis (EXEL) United States $9.693B 22.04
Bio-Rad Laboratories (BIO.B) United States $9.116B 30.98
Intra-Cellular Therapies (ITCI) United States $8.931B 0.00
Roivant Sciences (ROIV) United Kingdom $8.794B 0.00
Ascendis Pharma (ASND) Denmark $8.374B 0.00
Repligen (RGEN) United States $8.015B 104.42
Jazz Pharmaceuticals (JAZZ) Ireland $7.482B 7.32
Revolution Medicines (RVMD) United States $7.402B 0.00
Legend Biotech (LEGN) United States $6.343B 0.00
Halozyme Therapeutics (HALO) United States $6.108B 13.80
Cytokinetics (CYTK) United States $5.774B 0.00
Nuvalent (NUVL) United States $5.683B 0.00
Blueprint Medicines (BPMC) United States $5.539B 0.00
Telix Pharmaceuticals (TLX) Australia $5.021B 0.00
TG Therapeutics (TGTX) United States $4.835B 0.00
Alkermes (ALKS) Ireland $4.652B 15.62
Viking Therapeutics (VKTX) United States $4.582B 0.00
Krystal Biotech (KRYS) United States $4.501B 74.52
Arcellx (ACLX) United States $4.258B 0.00
ADMA Biologics Inc (ADMA) United States $4.248B 44.92
Axsome Therapeutics (AXSM) United States $4.232B 0.00
Scholar Rock Holding (SRRK) United States $4.134B 0.00
Apellis Pharmaceuticals (APLS) United States $4.125B 0.00
Alvotech (ALVO) Luxembourg $3.968B 0.00
Guardant Health (GH) United States $3.925B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.916B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.800B 0.00
Biohaven (BHVN) United States $3.770B 0.00
Avidity Biosciences (RNA) United States $3.720B 0.00
Immunovant (IMVT) United States $3.698B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.692B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.536B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.423B 0.00
NovoCure (NVCR) Jersey $3.245B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.105B 23.92
Xenon Pharmaceuticals (XENE) Canada $3.063B 0.00
Denali Therapeutics (DNLI) United States $2.999B 0.00
Merus (MRUS) Netherlands $2.896B 0.00
Janux Therapeutics (JANX) United States $2.794B 0.00
Amicus Therapeutics (FOLD) United States $2.782B 0.00
Vericel (VCEL) United States $2.720B 918.50
Zai Lab (ZLAB) China $2.715B 0.00
Twist Bioscience (TWST) United States $2.689B 0.00
SpringWorks Therapeutics (SWTX) United States $2.684B 0.00
Vera Therapeutics (VERA) United States $2.672B 0.00
Kymera Therapeutics (KYMR) United States $2.648B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.629B 0.00
Edgewise Therapeutics (EWTX) United States $2.559B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.445B 0.00
Iovance Biotherapeutics (IOVA) United States $2.374B 0.00
Mesoblast (MESO) Australia $2.353B 0.00
Protagonist Therapeutics (PTGX) United States $2.323B 14.65
CG Oncology (CGON) United States $2.203B 0.00
Geron (GERN) United States $2.176B 0.00
IDEAYA Biosciences (IDYA) United States $2.175B 0.00
Bavarian Nordic (BVNRY) Denmark $2.136B 13.09
Apogee Therapeutics (APGE) United States $2.123B 0.00
NeoGenomics (NEO) United States $2.117B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.108B 0.00
Ligand Pharmaceuticals (LGND) United States $2.049B 51.14
Beam Therapeutics (BEAM) United States $2.045B 0.00
WAVE Life Sciences (WVE) Singapore $2.031B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.018B 0.00
Belite Bio (BLTE) United States $2.000B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.986B 16.51
Akero Therapeutics (AKRO) United States $1.960B 0.00
Disc Medicine (IRON) United States $1.858B 0.00
Galapagos (GLPG) Belgium $1.838B 0.00
MannKind (MNKD) United States $1.820B 47.14
Agios Pharmaceuticals (AGIO) United States $1.816B 0.00
ImmunityBio (IBRX) United States $1.791B 0.00
Certara (CERT) United States $1.716B 48.46
Celldex Therapeutics (CLDX) United States $1.711B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.704B 0.00
Dynavax Technologies (DVAX) United States $1.696B 99.23
Fortrea Holdings (FTRE) United States $1.673B 53.29
Structure Therapeutics (GPCR) United States $1.614B 0.00
Viridian Therapeutics (VRDN) United States $1.565B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.492B 0.00
Praxis Precision Medicines (PRAX) United States $1.482B 0.00
Travere Therapeutics (TVTX) United States $1.481B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.440B 0.00
Arcus Biosciences (RCUS) United States $1.385B 0.00
Nurix Therapeutics (NRIX) United States $1.382B 0.00
Novavax (NVAX) United States $1.373B 0.00
MiMedx (MDXG) United States $1.364B 35.69
Arvinas (ARVN) United States $1.298B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.282B 0.00
Intellia Therapeutics (NTLA) United States $1.245B 0.00
Myriad Genetics (MYGN) United States $1.229B 0.00
Spyre Therapeutics (SYRE) United States $1.227B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.202B 0.00
ANI Pharmaceuticals (ANIP) United States $1.166B 15.89
Rocket Pharmaceuticals (RCKT) United States $1.160B 0.00
Gyre Therapeutics (GYRE) United States $1.122B 0.00
Anavex Life Sciences (AVXL) United States $1.031B 0.00
Liquidia Technologies (LQDA) United States $1.024B 0.00
Zymeworks (ZYME) United States $1.018B 0.00
Vir Biotechnology (VIR) United States $1.001B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.992B 0.00
Septerna (SEPN) United States $0.948B 0.00
ArriVent BioPharma (AVBP) United States $0.926B 0.00
Bicara Therapeutics (BCAX) United States $0.921B 0.00
Poseida Therapeutics (PSTX) United States $0.919B 0.00
Adaptive Biotechnologies (ADPT) United States $0.914B 0.00
AbCellera Biologics (ABCL) Canada $0.895B 0.00
Immatics (IMTX) Germany $0.886B 0.00
UniQure (QURE) Netherlands $0.880B 0.00
Upstream Bio (UPB) United States $0.874B 0.00
Nuvation Bio (NUVB) United States $0.872B 0.00
Cogent Biosciences (COGT) United States $0.862B 0.00
Replimune (REPL) United States $0.859B 0.00
89BIO (ETNB) United States $0.847B 0.00
Pacira BioSciences (PCRX) United States $0.846B 7.97
Cytek Biosciences (CTKB) United States $0.846B 0.00
Pliant Therapeutics (PLRX) United States $0.808B 0.00
Avid Bioservices (CDMO) United States $0.788B 0.00
Castle Biosciences (CSTL) United States $0.785B 140.20
LENZ Therapeutics (LENZ) United States $0.778B 0.00
CureVac (CVAC) Germany $0.772B 6.27
Erasca (ERAS) United States $0.763B 0.00
Prothena (PRTA) Ireland $0.736B 0.00
Tyra Biosciences (TYRA) United States $0.730B 0.00
Cullinan Therapeutics (CGEM) United States $0.721B 0.00
Pharming Group (PHAR) Netherlands $0.710B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.700B 0.00
CARGO Therapeutics (CRGX) United States $0.693B 0.00
Dianthus Therapeutics (DNTH) United States $0.687B 0.00
Oculis Holding AG (OCS) Switzerland $0.686B 0.00
Kura Oncology (KURA) United States $0.675B 0.00
Tectonic Therapeutic (TECX) United States $0.674B 0.00
Rapport Therapeutics (RAPP) United States $0.673B 0.00
Immunome (IMNM) United States $0.657B 0.00
Entrada Therapeutics (TRDA) United States $0.653B 10.98
Humacyte (HUMA) United States $0.652B 0.00
Keros Therapeutics (KROS) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Arbutus Biopharma (ABUS) United States $0.623B 0.00
MBX Biosciences (MBX) United States $0.610B 0.00
Mineralys Therapeutics (MLYS) United States $0.610B 0.00
GRAIL (GRAL) United States $0.602B 0.00
Stoke Therapeutics (STOK) United States $0.597B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.587B 0.00
Annexon (ANNX) United States $0.586B 0.00
Oric Pharmaceuticals (ORIC) United States $0.583B 0.00
Emergent Biosolutions (EBS) United States $0.556B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.553B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.548B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.531B 0.00
Astria Therapeutics (ATXS) United States $0.506B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.501B 0.00
CorMedix Inc (CRMD) United States $0.499B 0.00
Third Harmonic Bio (THRD) United States $0.497B 0.00
MeiraGTx Holdings (MGTX) United States $0.490B 0.00
Celcuity (CELC) United States $0.488B 0.00
Terns Pharmaceuticals (TERN) United States $0.482B 0.00
PureTech Health (PRTC) United States $0.466B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.462B 0.00
Abivax SA (ABVX) France $0.462B 0.00
Allogene Therapeutics (ALLO) United States $0.461B 0.00
Kodiak Sciences (KOD) United States $0.454B 0.00
Alpha Teknova (TKNO) United States $0.444B 0.00
MaxCyte (MXCT) United States $0.439B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.437B 0.00
Cartesian Therapeutics (RNAC) United States $0.430B 0.00
ChromaDex (CDXC) United States $0.419B 548.00
Aura Biosciences (AURA) United States $0.413B 0.00
GH Research (GHRS) Ireland $0.412B 0.00
Codexis (CDXS) United States $0.407B 0.00
AnaptysBio (ANAB) United States $0.407B 0.00
Prime Medicine (PRME) United States $0.392B 0.00
REGENXBIO (RGNX) United States $0.389B 0.00
Alumis (ALMS) United States $0.388B 0.00
Zenas BioPharma (ZBIO) United States $0.377B 0.00
Contineum Therapeutics (CTNM) United States $0.373B 0.00
Eton Pharmaceuticals (ETON) United States $0.373B 0.00
IGM Biosciences (IGMS) United States $0.369B 0.00
Sana Biotechnology (SANA) United States $0.368B 0.00
Kamada (KMDA) Israel $0.364B 22.61
Northwest Biotherapeutics (NWBO) United States $0.363B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.357B 0.00
Sage Therapeutics (SAGE) United States $0.354B 0.00
Design Therapeutics (DSGN) United States $0.349B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.349B 0.00
Neurogene (NGNE) United States $0.340B 0.00
Tango Therapeutics (TNGX) United States $0.336B 0.00
Trevi Therapeutics (TRVI) United States $0.335B 0.00
ACELYRIN, INC (SLRN) United States $0.331B 0.00
ATyr Pharma (ATYR) United States $0.328B 0.00
Voyager Therapeutics (VYGR) United States $0.326B 8.41
Prima BioMed (IMMP) Australia $0.322B 0.00
Revance Therapeutics (RVNC) United States $0.319B 0.00
Olema Pharmaceuticals (OLMA) United States $0.319B 0.00
Neumora Therapeutics (NMRA) United States $0.318B 0.00
Jasper Therapeutics (JSPR) United States $0.316B 0.00
Precigen (PGEN) United States $0.316B 0.00
EnGene Holdings (ENGN) Canada $0.312B 0.00
Absci (ABSI) United States $0.311B 0.00
XOMA Royalty (XOMA) United States $0.306B 0.00
Chimerix (CMRX) United States $0.305B 0.00
Rezolute (RZLT) United States $0.298B 0.00
Candel Therapeutics (CADL) United States $0.292B 0.00
Atea Pharmaceuticals (AVIR) United States $0.289B 0.00
Verastem (VSTM) United States $0.289B 0.00
ITeos Therapeutics (ITOS) United States $0.289B 0.00
AC Immune (ACIU) Switzerland $0.282B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.281B 0.00
Benitec Biopharma (BNTC) United States $0.280B 0.00
Ocugen (OCGN) United States $0.262B 0.00
Fulcrum Therapeutics (FULC) United States $0.261B 0.00
C4 Therapeutics (CCCC) United States $0.258B 0.00
Abeona Therapeutics (ABEO) United States $0.257B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.256B 0.00
Foghorn Therapeutics (FHTX) United States $0.255B 0.00
Urogen Pharma (URGN) United States $0.251B 0.00
Lifecore Biomedical (LFCR) United States $0.245B 0.00
Artiva Biotherapeutics (ARTV) United States $0.242B 0.00
Anika Therapeutics (ANIK) United States $0.237B 0.00
BioStem Technologies (BSEM) $0.237B 20.90
Sangamo Therapeutics (SGMO) United States $0.236B 0.00
DiaMedica Therapeutics (DMAC) United States $0.236B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.224B 0.00
Inhibrx Biosciences (INBX) United States $0.221B 0.00
Gossamer Bio (GOSS) United States $0.220B 0.00
Cardiff Oncology (CRDF) United States $0.218B 0.00
Opthea (OPT) Australia $0.215B 0.00
Amarin (AMRN) Ireland $0.215B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.214B 0.00
Nautilus Biotechnology (NAUT) United States $0.212B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.205B 0.00
Fate Therapeutics (FATE) United States $0.204B 0.00
BioAge Labs (BIOA) United States $0.199B 0.00
Molecular Partners AG (MOLN) Switzerland $0.197B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.193B 0.00
Compass Therapeutics (CMPX) United States $0.193B 0.00
Cidara Therapeutics (CDTX) United States $0.192B 0.00
GENFIT S.A (GNFT) France $0.191B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.191B 0.00
Semper Paratus Acquisition (TVGN) United States $0.186B 0.00
Alector (ALEC) United States $0.185B 0.00
Inozyme Pharma (INZY) United States $0.183B 0.00
Bright Minds Biosciences (DRUG) United States $0.182B 0.00
ScPharmaceuticals (SCPH) United States $0.179B 0.00
Nkarta (NKTX) United States $0.176B 0.00
TuHURA Biosciences (HURA) United States $0.174B 0.00
Mersana Therapeutics (MRSN) United States $0.173B 0.00
Adherex Technologies (FENC) United States $0.173B 0.00
Kyverna Therapeutics (KYTX) United States $0.169B 0.00
TScan Therapeutics (TCRX) United States $0.165B 0.00
Coherus BioSciences (CHRS) United States $0.161B 0.00
Checkpoint Therapeutics (CKPT) United States $0.161B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.160B 0.00
Sutro Biopharma (STRO) United States $0.159B 0.00
Solid Biosciences (SLDB) United States $0.156B 0.00
Actuate Therapeutics (ACTU) United States $0.155B 0.00
Innate Pharma S.A (IPHA) France $0.155B 0.00
Greenwich LifeSciences (GLSI) United States $0.154B 0.00
Zura Bio (ZURA) United States $0.153B 0.00
Puma Biotechnology (PBYI) United States $0.153B 6.50
2seventy Bio (TSVT) United States $0.153B 0.00
Caribou Biosciences (CRBU) United States $0.152B 0.00
Ventyx Biosciences (VTYX) United States $0.151B 0.00
Compugen (CGEN) Israel $0.147B 82.50
InflaRx (IFRX) Germany $0.147B 0.00
Seres Therapeutics (MCRB) United States $0.144B 0.00
Aligos Therapeutics (ALGS) United States $0.143B 0.00
Instil Bio (TIL) United States $0.141B 0.00
Climb Bio (CLYM) United States $0.139B 0.00
Sagimet Biosciences (SGMT) United States $0.138B 0.00
Seer (SEER) United States $0.137B 0.00
Biomea Fusion (BMEA) United States $0.134B 0.00
X4 Pharmaceuticals (XFOR) United States $0.128B 0.00
XBiotech (XBIT) United States $0.127B 0.00
Leap Therapeutics (LPTX) United States $0.123B 0.00
PepGen (PEPG) United States $0.123B 0.00
Renovaro (RENB) United States $0.121B 0.00
Black Diamond Therapeutics (BDTX) United States $0.121B 0.00
Akoya Biosciences (AKYA) United States $0.120B 0.00
Alto Neuroscience (ANRO) United States $0.118B 0.00
Elutia (ELUT) United States $0.118B 0.00
Monopar Therapeutics (MNPR) United States $0.117B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.116B 0.00
Cabaletta Bio (CABA) United States $0.114B 0.00
TELA Bio (TELA) United States $0.113B 0.00
Tenaya Therapeutics (TNYA) United States $0.112B 0.00
Inventiva S.A (IVA) France $0.112B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.111B 0.00
Allakos (ALLK) United States $0.111B 0.00
INmune Bio (INMB) United States $0.109B 0.00
Editas Medicine (EDIT) United States $0.108B 0.00
Applied Therapeutics (APLT) United States $0.105B 0.00
MediciNova (MNOV) United States $0.104B 0.00
Nuvectis Pharma (NVCT) United States $0.104B 0.00
HilleVax (HLVX) United States $0.104B 0.00
Cellectis S.A (CLLS) France $0.101B 0.00
BioHarvest Sciences (BHST) Canada $0.101B 0.00
Adverum Biotechnologies (ADVM) United States $0.100B 0.00
CAMP4 Therapeutics (CAMP) United States $0.099B 0.00
Coya Therapeutics (COYA) United States $0.095B 0.00
23andMe Holding (ME) United States $0.093B 0.00
Invizyne Technologies (IZTC) United States $0.093B 0.00
VistaGen Therapeutics (VTGN) United States $0.092B 0.00
Immunic (IMUX) United States $0.092B 0.00
Adagene (ADAG) China $0.091B 0.00
Adlai Nortye (ANL) Cayman Islands $0.090B 0.00
Alpha Cognition (ACOG) Canada $0.088B 0.00
Skye Bioscience (SKYE) United States $0.086B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.085B 0.00
Citius Oncology (CTOR) United States $0.085B 0.00
Theratechnologies (THTX) Canada $0.085B 0.00
Bluebird Bio (BLUE) United States $0.084B 0.00
Scilex Holding (SCLX) United States $0.084B 0.00
Rani Therapeutics Holdings (RANI) United States $0.084B 0.00
Genelux (GNLX) United States $0.083B 0.00
CytomX Therapeutics (CTMX) United States $0.083B 6.24
Genenta Science S.p.A (GNTA) Italy $0.083B 0.00
Quince Therapeutics (QNCX) United States $0.083B 0.00
ALX Oncology Holdings (ALXO) United States $0.082B 0.00
Atara Biotherapeutics (ATRA) United States $0.082B 0.00
Abpro Holdings (ABP) United States $0.081B 0.00
Entera Bio (ENTX) Israel $0.081B 0.00
Adicet Bio (ACET) United States $0.080B 0.00
Ikena Oncology (IKNA) United States $0.080B 0.00
Aerovate Therapeutics (AVTE) United States $0.078B 0.00
Aadi Bioscience (AADI) United States $0.077B 0.00
Vor Biopharma (VOR) $0.077B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
ZIVO Bioscience (ZIVO) United States $0.076B 0.00
Galena Biopharma (SLS) United States $0.075B 0.00
Generation Bio (GBIO) United States $0.074B 0.00
I-Mab (IMAB) China $0.074B 0.00
Agenus (AGEN) United States $0.072B 0.00
Clearside Biomedical (CLSD) United States $0.072B 0.00
Vigil Neuroscience (VIGL) United States $0.072B 0.00
Oncolytics Biotech (ONCY) Canada $0.072B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.072B 0.00
Annovis Bio (ANVS) United States $0.071B 0.00
FibroBiologics (FBLG) United States $0.070B 0.00
Werewolf Therapeutics (HOWL) United States $0.070B 0.00
Cue Biopharma (CUE) United States $0.069B 0.00
Immuneering (IMRX) United States $0.069B 0.00
Ovid Therapeutics (OVID) United States $0.068B 0.00
Connect Biopharma Holdings (CNTB) United States $0.067B 0.00
DBV Technologies S.A (DBVT) France $0.067B 0.00
PDS Biotechnology (PDSB) United States $0.065B 0.00
BGM Group (BGM) China $0.065B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.063B 0.00
BeyondSpring (BYSI) United States $0.062B 0.00
IO Biotech (IOBT) Denmark $0.061B 0.00
Boundless Bio (BOLD) United States $0.061B 0.00
Immix Biopharma (IMMX) United States $0.061B 0.00
Spero Therapeutics (SPRO) United States $0.059B 15.43
Kronos Bio (KRON) United States $0.059B 0.00
Fortress Biotech (FBIO) United States $0.059B 0.00
Shattuck Labs (STTK) United States $0.058B 0.00
Invivyd (IVVD) United States $0.057B 0.00
Rapt Therapeutics (RAPT) United States $0.057B 0.00
Repare Therapeutics (RPTX) Canada $0.056B 0.00
Elicio Therapeutics (ELTX) United States $0.055B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.053B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.052B 0.00
Dyadic (DYAI) United States $0.051B 0.00
Oncobiologics (OTLK) United States $0.051B 0.00
Passage Bio (PASG) United States $0.051B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.050B 0.00
Aileron Therapeutics (ALRN) United States $0.049B 0.00
Celularity (CELU) United States $0.048B 0.00
Kezar Life Sciences (KZR) United States $0.048B 0.00
Xilio Therapeutics (XLO) United States $0.047B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.047B 0.00
Clene (CLNN) United States $0.045B 0.00
CalciMedica (CALC) United States $0.044B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.044B 0.00
Omega Therapeutics (OMGA) United States $0.043B 0.00
VTv Therapeutics (VTVT) United States $0.043B 0.00
Q32 Bio (QTTB) United States $0.042B 0.00
AN2 Therapeutics (ANTX) United States $0.042B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.041B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
Estrella Immunopharma (ESLA) United States $0.041B 0.00
Lexaria Bioscience (LEXX) Canada $0.040B 0.00
MiNK Therapeutics (INKT) United States $0.040B 0.00
Opus Genetics (IRD) United States $0.040B 0.00
Exicure (XCUR) United States $0.040B 0.00
Rallybio (RLYB) United States $0.039B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.038B 0.00
OKYO Pharma (OKYO) $0.038B 0.00
Enzo Biochem (ENZ) United States $0.038B 0.00
Forte Biosciences (FBRX) United States $0.037B 0.00
Precision BioSciences (DTIL) United States $0.036B 0.00
Curis (CRIS) United States $0.036B 0.00
Lantern Pharma (LTRN) United States $0.036B 0.00
KALA BIO (KALA) United States $0.036B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.035B 0.00
Elevation Oncology (ELEV) United States $0.035B 0.00
SAB Biotherapeutics (SABS) United States $0.034B 0.00
LakeShore Biopharma (LSB) China $0.034B 0.00
RenovoRx (RNXT) United States $0.033B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.032B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
Chemomab Therapeutics (CMMB) Israel $0.031B 0.00
Cognition Therapeutics (CGTX) United States $0.030B 0.00
Lisata Therapeutics (LSTA) United States $0.030B 0.00
BioAtla (BCAB) United States $0.030B 0.00
OnKure Therapeutics (OKUR) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Pulmatrix (PULM) United States $0.028B 0.00
Cadrenal Therapeutics (CVKD) United States $0.028B 0.00
Prana Biotechnology (ATHE) Australia $0.027B 0.00
Equillium (EQ) United States $0.027B 0.00
Medicus Pharma (MDCX) Canada $0.027B 0.00
Longeveron (LGVN) United States $0.027B 0.00
Intensity Therapeutics (INTS) United States $0.026B 0.00
Bionano Genomics (BNGO) United States $0.026B 0.00
Beyond Air (XAIR) United States $0.026B 0.00
BRIACELL THERAP (BCTX) Canada $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
Cara Therapeutics (CARA) United States $0.024B 0.00
NKGen Biotech (NKGN) United States $0.024B 0.00
Pluri (PLUR) Israel $0.024B 0.00
Cocrystal Pharma (COCP) United States $0.024B 0.00
HOOKIPA Pharma (HOOK) United States $0.024B 0.00
GeoVax Labs (GOVX) United States $0.023B 0.00
NextCure (NXTC) United States $0.023B 0.00
Gelteq (GELS) Australia $0.022B 0.00
Tenax Therapeutics (TENX) United States $0.022B 0.00
Bolt Biotherapeutics (BOLT) United States $0.022B 0.00
Affimed (AFMD) Germany $0.022B 0.00
Athira Pharma (ATHA) United States $0.021B 0.00
Ocean Biomedical (OCEA) United States $0.021B 0.00
IN8bio (INAB) United States $0.020B 0.00
BioXcel Therapeutics (BTAI) United States $0.019B 0.00
Aprea Therapeutics (APRE) United States $0.019B 0.00
UNITY Biotechnology (UBX) United States $0.019B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.019B 0.00
MetaVia (MTVA) United States $0.018B 0.00
Senti Biosciences (SNTI) United States $0.017B 0.00
Spruce Biosciences (SPRB) United States $0.017B 0.00
Cyclo Therapeutics (CYTH) United States $0.017B 0.00
HCW Biologics (HCWB) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Cingulate (CING) United States $0.016B 0.00
Palvella Therapeutics (PVLA) United States $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.016B 0.00
Imunon (IMNN) United States $0.015B 0.00
BioAffinity Technologies (BIAF) United States $0.015B 0.00
Carmell (CTCX) United States $0.014B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.014B 0.00
Aptose Biosciences (APTO) Canada $0.014B 0.00
CervoMed (CRVO) United States $0.014B 0.00
Eyenovia (EYEN) United States $0.013B 0.00
Sensei Biotherapeutics (SNSE) United States $0.013B 0.00
Turnstone Biologics (TSBX) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Apollomics (APLM) United States $0.012B 0.00
Ensysce Biosciences (ENSC) United States $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
Evogene (EVGN) Israel $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
COSCIENS Biopharma (CSCI) Canada $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Mainz Biomed (MYNZ) Germany $0.009B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
ABVC BioPharma (ABVC) United States $0.008B 0.00
Vincerx Pharma (VINC) United States $0.008B 0.00
Quantum Biopharma (QNTM) Canada $0.008B 0.00
Polyrizon (PLRZ) Israel $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Novogen (KZIA) Australia $0.008B 0.00
GRI Bio (GRI) United States $0.008B 0.00
Galecto (GLTO) Denmark $0.008B 0.00
Soligenix (SNGX) United States $0.007B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.007B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
CNS Pharmaceuticals (CNSP) United States $0.007B 0.00
Edesa Biotech (EDSA) Canada $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Syros Pharmaceuticals (SYRS) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
Moleculin Biotech (MBRX) United States $0.006B 0.00
Evaxion Biotech (EVAX) Denmark $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
NAYA Biosciences (NAYA) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Windtree Therapeutics (WINT) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00